Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARAP1 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1) is a large multifunctional protein containing ArfGAP, RhoGAP, ankyrin repeats, SAM, and multiple pleckstrin homology (PH) domains[1][4]. It functions as a phosphoinositide-activated GTPase-activating protein (GAP), regulating both Arf and Rho family small GTPases, with a role in actin cytoskeleton remodeling, intracellular trafficking, and the assembly of actin-rich structures such as podosomes and sealing zones in osteoclasts[1][2][4]. ARAP1 is essential for the regulated trafficking of lysosomal membrane proteins and maintenance of proper bone resorption, and alterations in its activity are linked to bone, metabolic, and retinal diseases[1][2][6]. It acts as a molecular bridge between F-actin dynamics and membrane trafficking, affecting cell shape, movement, and specialized membrane domains[2][4]. Multiple alternative transcripts and isoforms exist, and homologs are found in mammalian species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 (ARAP1).